US FDA approves Flexion ’s Zilretta to treat osteoarthritis knee pain

The US Food and Drug Administration (FDA) has granted approval for specialist pharmaceutical firm Flexion Therapeutics ’s Zilretta for the treatment of osteoarthritis (OA) knee pain.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news